Veru (VERU) Current Deferred Tax Assets (2010 - 2016)
Veru (VERU) posted quarterly Current Deferred Tax Assets of $2.0 million for Q4 2016, up 624.1% year-over-year from $279659.0 in Q1 2016, and little changed quarter-over-quarter from $2.0 million in Q3 2016.
Veru (VERU) Current Deferred Tax Assets (2010 - 2016) Analysis & Trends
Veru (VERU) has reported Current Deferred Tax Assets for 7 consecutive years, with $2.0 million the latest figure, recorded in Q4 2016.
- In Q4 2016, Current Deferred Tax Assets rose 624.1% year-over-year to $2.0 million; the TTM figure through Dec 2016 stood at $2.0 million (up 624.1% YoY), while the FY2016 annual figure was $2.0 million, up 99.31% from the prior year.
- Current Deferred Tax Assets held at $2.0 million in Q4 2016 per VERU's latest filing, from $2.0 million in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $2.6 million in Q3 2013 and bottomed at $129000.0 in Q4 2014.
- Historically, Current Deferred Tax Assets has averaged $1.4 million across 5 years, with a median of $1.3 million in 2014.
- Annual changes were most pronounced in 2014 — Current Deferred Tax Assets slumped 94.95% — and 2016, when it jumped 624.1%.
- Veru's Current Deferred Tax Assets stood at $2.2 million in 2012, then grew by 18.59% to $2.6 million in 2013, then plunged by 94.95% to $129000.0 in 2014, then soared by 116.79% to $279659.0 in 2015, then surged by 624.1% to $2.0 million in 2016.
- Business Quant data shows VERU's Current Deferred Tax Assets at $2.0 million in Q4 2016, $2.0 million in Q3 2016, and $244105.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 2.03 Mn |
| Dec 31, 2016 | 2.03 Mn |
| Sep 30, 2016 | 2.03 Mn |
| Sep 30, 2016 | 2.03 Mn |
| Jun 30, 2016 | 244,105.00 |
| Jun 30, 2016 | 244,105.00 |
| Mar 31, 2016 | 362,847.00 |
| Mar 31, 2016 | 362,847.00 |
| Dec 31, 2015 | 279,659.00 |
| Dec 31, 2015 | 279,659.00 |
| Sep 30, 2015 | 1.02 Mn |
| Sep 30, 2015 | 1.02 Mn |
| Jun 30, 2015 | 828,000.00 |
| Jun 30, 2015 | 828,000.00 |
| Mar 31, 2015 | 700,000.00 |
| Mar 31, 2015 | 700,000.00 |
| Dec 31, 2014 | 129,000.00 |
| Dec 31, 2014 | 129,000.00 |
| Sep 30, 2014 | 711,000.00 |
| Sep 30, 2014 | 711,000.00 |